Efficacy of novel compression gloves and stockings for prevention oxaliplatin induced peripheral neuropathy, the randomized controlled trial

Ratchadapiseksompotch Fund, Graduate Affairs, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 48 人开始时间: 2022年11月7日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•a.Colorectal cancer patients or gastric cancer patients with histopathological proven who plan for treatment with standard dose of Oxaliplatin-based regimen at King Chulalongkorn Memorial Hospital
•b.Age between 18 to 65 years old
•c.Patients with Eastern Cooperative Oncology Group (ECOG) performance status scale 0-2
•d.Fully conscious patients with ability to written consent in a consent form
•e.Complete blood count, liver function test, and renal function test are not contraindicated for chemotherapy.

•a.Patients who have previous neuropathy or neurological disease
•b.Patients who are diagnosed by history taking and physical examination as diabetes mellitus with diabetic neuropathy, active hypothyroidism, HIV infection, hepatitis viral infection, and peripheral arterial disease.
•c.Patients who use other complementary medicines
•d.Patients who are diagnosed as second primary cancer other than colorectal cancer or gastric cancer
•e.Patients who diagnosed as uncontrolled psychiatric disease
•f.Patients who are pregnant
•g.Patients who are in breastfeeding process

发起方

Ratchadapiseksompotch Fund, Graduate Affairs, Faculty of Medicine, Chulalongkorn University